Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Copyright/Patent/Trademark
Antitrust Legislation ---Oversight Pharmacy Benefit Managers Artificial Intelligence (AI) ---Patent eligibility for inventions created using AI tools Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---March-In Rights ---NIST RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March in Rights ---Reasonable Pricing Clause Compulsory Licensing Data Privacy Issues ---H.R.7085: BIOSECURE Act ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---S.3558: A bill to prohibit contracting with certain biotechnology providers, and for other purposes. ---H.R.8818: American Privacy Rights Act of 2024 ---Bio COMPETES (Draft) ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern ---House GOP RFI on Supply Chain Diversity in Patenting ---S.2566: Inventor Diversity for Economic Advancement (IDEA) Act Drug Patenting ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.113: Prescription Pricing for the People Act of 2023 ---S.142: Preserve Access to Affordable Generics and Biosimilars Act ---S.148: Stop STALLING Act ---S.150: Affordable Prescriptions for Patients Act of 2023 ---S.1128: A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents. ---S.2780: Medication Affordability and Patient Integrity Act ---S.3583/H.R.6986: A bill to address patent thickets ---S.5573: A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products. ---H.R.5475: Prohibiting Adversarial Patents Act of 2023 (Fitzgerald - WI) ---H.R.6275: Protecting Consumer Access to Generic Drugs Act ---FTC Orange Book Delisting Initiative ---Orange Book Listing ---PTO Proposed Rules on Terminal Disclaimer Practice ---Restrictions on Intellectual Property Rights Foreign Drug Data Protection Law ---H.R.7085: BIOSECURE Act ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---Bio COMPETES (Draft) ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern ---House GOP RFI on Supply Chain Intellectual Property Enforcement ---China ---TRIPS Waiver Patent Reform ---H.R.4575: Prohibiting Adversarial Patents Act (PAPA) ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.2140: Patent Eligibility Restoration Act (PERA) ---S.2220/H.R.4370: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act ---Patent Litigation Reform ---The USPTO Request for Comments: Experimental Use Defense 89 Fed.Reg 53963 Patenting of Biological Inventions ---S.2140: Patent Eligibility Restoration Act (PERA) ---Section 101 Modernization World Health Organization (WHO) ---WHO Pandemic Preparedness Accord World Intellectual Property Office (WIPO) ---Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge World Trade Organization (WTO) ---TRIPS Waiver
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,460,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2024 · fourth_quarter · Copyright/Patent/Trademark
S.4875/H.R. 9551, the NO FAKES Act of 2023 S. 2780, the Medication Affordability and Patent Integrity Act H.R. 9455/ S. the IDEA Act H.R. 9211/S. 4840, the RESTORE Patent Rights Act of 2024 S. 5160, Sharing of information with respect to suspected violations of intellectual property rights. H.R. 8134, the Restoring America's Leadership in Innovation Act of 2024 (RALIA) H.R. 8132, Balancing Incentives Act of 2024 H.R. 7913, Generative AI Copyright Disclosure Act of 2024 H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act H.R. 9474/S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
2024 · third_quarter · Copyright/Patent/Trademark
Antitrust Legislation ---Oversight Pharmacy Benefit Managers Artificial Intelligence (AI) Bayh-Dole Act/Tech Transfer ---S.1956 Invent Here, Make Here Act of 2023 (Baldwin) ---Bayh-Dole Act ---March-In Rights ---NIST RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March in Rights ---Reasonable Pricing Clause Compulsory Licensing Data Privacy Issues ---H.R.7085: BIOSECURE Act ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---S.3558: A bill to prohibit contracting with certain biotechnology providers, and for other purposes. ---H.R. 8818: American Privacy Rights Act of 2024 ---Bio COMPETES (Draft) ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern ---House GOP RFI on Supply Chain Diversity in Patenting ---S.2566: Inventor Diversity for Economic Advancement (IDEA) Act Drug Patenting ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.113: Prescription Pricing for the People Act of 2023 ---S.142: Preserve Access to Affordable Generics and Biosimilars Act ---S.148: Stop STALLING Act ---S.150: Affordable Prescriptions for Patients Act of 2023 ---S.1128: A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents ---S. 2780 - Medication Affordability and Patient Integrity Act ---S.3583/H.R.6986: A bill to address patent thickets ---H.R.5475 Prohibiting Adversarial Patents Act of 2023 (Fitzgerald - WI) ---H.R. 6275 Protecting Consumer Access to Generic Drugs Act ---FTC Orange Book Delisting Initiative ---Orange Book Listing ---PTO Proposed Rules on Terminal Disclaimer Practice ---Restrictions on Intellectual Property Rights Foreign Drug Data Protection Law ---H.R.7085: BIOSECURE Act ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---Bio COMPETES (Draft) ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern ---House GOP RFI on Supply Chain Intellectual Property Enforcement ---China ---TRIPS Waiver Patent Reform ---H.R.4575: Prohibiting Adversarial Patents Act (PAPA) ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.2140: Patent Eligibility Restoration Act (PERA) ---S.2220/H.R.4370: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act ---Patent Litigation Reform ---The USPTO Request for Comments: Experimental Use Defense 89 Fed.Reg 53963 Patenting of Biological Inventions ---S.2140: Patent Eligibility Restoration Act (PERA) ---Section 101 Modernization World Health Organization (WHO) ---WHO Pandemic Preparedness Accord World Intellectual Property Office (WIPO) ---Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge World Trade Organization (WTO) ---TRIPS Waiver
Client expense: $1,680,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2024 · third_quarter · Copyright/Patent/Trademark
S.4875/H.R. 9551, the NO FAKES Act of 2023 S. 2780, the Medication Affordability and Patent Integrity Act H.R. 9455/ S. the IDEA Act H.R. 9211/S. 4840, the RESTORE Patent Rights Act of 2024 S. 5160, Sharing of information with respect to suspected violations of intellectual property rights. H.R. 8134, the Restoring America's Leadership in Innovation Act of 2024 (RALIA) H.R. 8132, Balancing Incentives Act of 2024 H.R. 7913, Generative AI Copyright Disclosure Act of 2024 H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act H.R. 9474/S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request
Client expense: $10,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
2024 · second_quarter · Copyright/Patent/Trademark
Antitrust Legislation ---Oversight Pharmacy Benefit Managers Artificial Intelligence (AI) Bayh-Dole Act/Tech Transfer ---S.1956 Invent Here, Make Here Act of 2023 (Baldwin) ---Bayh-Dole Act ---March-In Rights ---Reasonable Pricing Clause ---NIST RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March in Rights Compulsory Licensing Data Privacy Issues ---H.R.7085: BIOSECURE Act ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---S.3558: A bill to prohibit contracting with certain biotechnology providers, and for other purposes. ---H.R. 8818: American Privacy Rights Act of 2024 ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern Diversity in Patenting ---S.2566: Inventor Diversity for Economic Advancement (IDEA) Act Drug Patenting ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.113: Prescription Pricing for the People Act of 2023 ---S.142: Preserve Access to Affordable Generics and Biosimilars Act ---S.148: Stop STALLING Act ---S.150: Affordable Prescriptions for Patients Act of 2023 ---S.1128: A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents ---S. 2780 - Medication Affordability and Patient Integrity Act ---S.3583/H.R.6986: A bill to address patent thickets ---H.R.5475 Prohibiting Adversarial Patents Act of 2023 (Fitzgerald - WI) ---H.R. 6275 Protecting Consumer Access to Generic Drugs Act ---FTC Orange Book Delisting Initiative ---Orange Book Listing ---PTO Proposed Rules on Terminal Disclaimer Practice ---Restrictions on Intellectual Property Rights Foreign Drug Data Protection Law ---H.R.7085: BIOSECURE Act ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---S.3558: A bill to prohibit contracting with certain biotechnology providers, and for other purposes. ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern Intellectual Property Enforcement ---China ---TRIPS Waiver Patent Reform ---H.R.4575: Prohibiting Adversarial Patents Act (PAPA) ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.2140: Patent Eligibility Restoration Act (PERA) ---S.2220/H.R.4370: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act ---Patent Litigation Reform Patenting of Biological Inventions ---S.2140: Patent Eligibility Restoration Act (PERA) ---Section 101 Modernization World Health Organization (WHO) ---WHO Pandemic Preparedness Accord World Intellectual Property Office (WIPO) ---Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge World Trade Organization (WTO) ---13th Ministerial Conference ---TRIPS Waiver
Client expense: $1,790,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), White House Office
2024 · second_quarter · Copyright/Patent/Trademark
H.R. 8134, the Restoring America's Leadership in Innovation Act of 2024 (RALIA) H.R. 8132, Balancing Incentives Act of 2024 H.R. 7913, Generative AI Copyright Disclosure Act of 2024 H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request
2024 · first_quarter · Copyright/Patent/Trademark
Antitrust Legislation Artificial Intelligence (AI) Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---March-In Rights ---Reasonable Pricing Clause ---NIST RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March in Rights Compulsory Licensing ---28 USC 1498 Government Use of Patents ---Prescription Drug Price Relief Act (Discussion Draft) Coronavirus (COVID-19) Pandemic ---Restrictions on Intellectual Property Rights ---TRIPS Waiver Data Privacy Issues ---H.R.7085: BIOSECURE Act -------At the direction of its core members, BIO advocated on behalf of the biotech industry to avoid supply chain disruptions that would interrupt treatments and cures for patients. During February 2024, BIO coordinated some of this advocacy with WuXiAppTec (then an associate member of BIO) and with other BIO members also, seeking removal of the list of entities specifically named in the proposed legislation being referenced as the BIOSECURE Act, which included WuXiAppTec. ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---S.3558: A bill to prohibit contracting with certain biotechnology providers, and for other purposes. ---American Data Privacy and Protection Act ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern ---Ranking Member Cassidy RFI on Improving Americans Health Data Privacy Diversity in Patenting ---S.2566: Inventor Diversity for Economic Advancement (IDEA) Act Drug Patenting ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.113: Prescription Pricing for the People Act of 2023 ---S.142: Preserve Access to Affordable Generics and Biosimilars Act ---S.148: Stop STALLING Act ---S.150: Affordable Prescriptions for Patients Act of 2023 ---S.1128: A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents ---S.3583/H.R.6986: A bill to address patent thickets ---CLEAR Patents Act ---Interagency Patent Coordination and Improvement Act ---Restrictions on Intellectual Property Rights Foreign Drug Data Protection Law ---H.R.7085: BIOSECURE Act -------At the direction of its core members, BIO advocated on behalf of the biotech industry to avoid supply chain disruptions that would interrupt treatments and cures for patients. During February 2024, BIO coordinated some of this advocacy with WuXiAppTec (then an associate member of BIO) and with other BIO members also, seeking removal of the list of entities specifically named in the proposed legislation being referenced as the BIOSECURE Act, which included WuXiAppTec. ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---S.3558: A bill to prohibit contracting with certain biotechnology providers, and for other purposes. ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern Intellectual Property Enforcement ---TRIPS Waiver Patent Reform ---H.R.3535: Advancing Americas Interest Act ---H.R.4575: Prohibiting Adversarial Patents Act (PAPA) ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.2140: Patent Eligibility Restoration Act (PERA) ---S.2220/H.R.4370: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act ---S.4417: Patent Trial and Appeal Board Reform Act of 2022 ---Patent Litigation Reform Patenting of Biological Inventions ---S.2140: Patent Eligibility Restoration Act (PERA) ---Section 101 Modernization ---PTO Examination Guidelines United States-Mexico-Canada Agreement (USMCA) ---Implementation of USMCA World Health Organization (WHO) ---WHO Pandemic Preparedness Accord World Intellectual Property Office (WIPO) ---Intergovernmental Committee on IP and Genetic Resources World Trade Organization (WTO) ---13th Ministerial Conference ---TRIPS Waiver
2024 · first_quarter · Copyright/Patent/Trademark
Antitrust Legislation Artificial Intelligence (AI) Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---March-In Rights ---Reasonable Pricing Clause ---NIST RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March in Rights Compulsory Licensing ---28 USC 1498 Government Use of Patents ---Prescription Drug Price Relief Act (Discussion Draft) Coronavirus (COVID-19) Pandemic ---Restrictions on Intellectual Property Rights ---TRIPS Waiver Data Privacy Issues ---H.R.7085: BIOSECURE Act -------At the direction of its core members, BIO advocated on behalf of the biotech industry to avoid supply chain disruptions that would interrupt treatments and cures for patients. During February 2024, BIO coordinated some of this advocacy with WuXiAppTec (then an associate member of BIO) and with other BIO members also, seeking removal of the list of entities specifically named in the proposed legislation being referenced as the BIOSECURE Act, which included WuXiAppTec. ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---S.3558: A bill to prohibit contracting with certain biotechnology providers, and for other purposes. ---American Data Privacy and Protection Act ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern ---Ranking Member Cassidy RFI on Improving Americans Health Data Privacy Diversity in Patenting ---S.2566: Inventor Diversity for Economic Advancement (IDEA) Act Drug Patenting ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.113: Prescription Pricing for the People Act of 2023 ---S.142: Preserve Access to Affordable Generics and Biosimilars Act ---S.148: Stop STALLING Act ---S.150: Affordable Prescriptions for Patients Act of 2023 ---S.1128: A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents ---S.3583/H.R.6986: A bill to address patent thickets ---CLEAR Patents Act ---Interagency Patent Coordination and Improvement Act ---Restrictions on Intellectual Property Rights Foreign Drug Data Protection Law ---H.R.7085: BIOSECURE Act -------At the direction of its core members, BIO advocated on behalf of the biotech industry to avoid supply chain disruptions that would interrupt treatments and cures for patients. During February 2024, BIO coordinated some of this advocacy with WuXiAppTec (then an associate member of BIO) and with other BIO members also, seeking removal of the list of entities specifically named in the proposed legislation being referenced as the BIOSECURE Act, which included WuXiAppTec. ---H.R.7520: Protecting Americans Data from Foreign Adversaries Act of 2024 ---S.3558: A bill to prohibit contracting with certain biotechnology providers, and for other purposes. ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern Intellectual Property Enforcement ---TRIPS Waiver Patent Reform ---H.R.3535: Advancing Americas Interest Act ---H.R.4575: Prohibiting Adversarial Patents Act (PAPA) ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.2140: Patent Eligibility Restoration Act (PERA) ---S.2220/H.R.4370: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act ---S.4417: Patent Trial and Appeal Board Reform Act of 2022 ---Patent Litigation Reform Patenting of Biological Inventions ---S.2140: Patent Eligibility Restoration Act (PERA) ---Section 101 Modernization ---PTO Examination Guidelines United States-Mexico-Canada Agreement (USMCA) ---Implementation of USMCA World Health Organization (WHO) ---WHO Pandemic Preparedness Accord World Intellectual Property Office (WIPO) ---Intergovernmental Committee on IP and Genetic Resources World Trade Organization (WTO) ---13th Ministerial Conference ---TRIPS Waiver
2024 · first_quarter · Copyright/Patent/Trademark
H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request
2023 · fourth_quarter · Budget/Appropriations
Law enforcement policy and operations, law enforcement grants and funding, law enforcement training, federal-local law enforcement partnerships, violent crime, gun violence, policing reform, officer health and wellness, recruitment and retention, criminal justice reform, Next Generation 911, spectrum policy, law enforcement communications, CJS appropriations, DHS appropriations, FEMA preparedness grants, alternative responses, criminal record sealing and expungement, reentry policy, VICTIM Act, hate crimes, asset forfeiture, gun safety, youth summer employment programs, mental health and substance abuse, Project Safe Neighborhoods, Extreme Risk Protection Orders, COPS grants, computer crime, IP theft, catalytic converter theft, Medicaid Inmate Exclusion Policy, forensic genetic genealogy, rape kit backlog, World Trade Center Health Program, H.R.3565 - Spectrum Auction Reauthorization Act of 2023, H.R.2670 - National Defense Authorization Act for Fiscal Year 2024, H.R.4632/S. 2298 - National ACERT Grant Program Authorization Act, H.R. 3150 - OPIOIDS Act, H.R. 1525 - FAIR Act, H.R.2770 - Prevent Family Fire Act of 2023, H.R.4283 - Gun Violence Prevention and Safe Communities Act of 2023, S.2644 - American Law Enforcement SAVER Act, S.1387/H.R. 4384 - Project Safe Neighborhoods Reauthorization Act of 2023, S.2214 - Fair Legal Access Grants Act, S.2313 - Driving for Opportunity Act of 2023, S.2567 - Stop Computer Crimes Proliferation Act of 2023, S. 546 - Recruit and Retain Act, H.R. 612/S. 154 - PART Act, S.2566 - American IDEA Act, H.R. 1105 - Debbie Smith Act of 2023, H.R. 5721 - Rape Kit Backlog Act of 2023, H.R. 4531 - SUPPORT Act, H.R.3074/S.971 - Due Process Continuity of Care Act, H.R. 2400 - Reentry Act, S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, S. 2625/H.R.4367 - Department of Homeland Security Appropriations Act, 2024
2023 · fourth_quarter · Homeland Security
Law enforcement policy and operations, law enforcement grants and funding, law enforcement training, federal-local law enforcement partnerships, Next Generation 911, spectrum policy, law enforcement communications, data privacy, law enforcement access to third-party data, American Data Privacy and Protection Act, CJS appropriations, DHS appropriations, FEMA preparedness grants, opioids, fentanyl, drug trafficking, asset forfeiture, human trafficking, ghost guns, firearms trafficking, counterterrorism and mass casualty attacks, cross-border smuggling, cUAS, counterfeit drugs, untraceable firearms, computer crime, IP theft, FirstNet, online child sexual exploitation, encryption, World Trade Center Health Program, Overt Human Intelligence Collection Program, 1033 Program, H.R.3565 - Spectrum Auction Reauthorization Act of 2023, H.R.2670 - National Defense Authorization Act for Fiscal Year 2024, H.R.4639 - Fourth Amendment Is Not For Sale Act, HH.R. 3150 - OPIOIDS Act, H.R.3563 - STRIP Act, H.R. 1525 - FAIR Act, H.R. 5460 - Bolstering Security Against Ghost Guns Act, S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023, S.2644 - American Law Enforcement SAVER Act, S.2292 - Purchased Data Inventory Act, S.2567 - Stop Computer Crimes Proliferation Act of 2023, S.2566 - American IDEA Act, H.R. S. 2103 - Intelligence Authorization for FY 2024, S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, S. 2625/H.R.4367 - Department of Homeland Security Appropriations Act, 2024
Client expense: $24,000 · Firm income: Not reported
2023 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Law enforcement policy and operations, law enforcement grants and funding, law enforcement training, federal-local law enforcement partnerships, violent crime, gun violence, firearms policy, criminal justice system accountability, policing reform, officer health and wellness, recruitment and retention, criminal justice reform, Next Generation 911, spectrum policy, law enforcement communications, bail reform, data privacy, law enforcement access to third-party data, American Data Privacy and Protection Act, CJS appropriations, DHS appropriations, FEMA preparedness grants, alternative responses, opioids, fentanyl, drug trafficking, criminal record sealing and expungement, reentry policy, parole, post-release supervision, VICTIM Act, hate crimes, asset forfeiture, human trafficking, gun safety, ghost guns, firearms trafficking, counterterrorism and mass casualty attacks, cross-border smuggling, cUAS, youth summer employment programs, juvenile crime, mental health and substance abuse, officer safety, Project Safe Neighborhoods, counterfeit drugs, untraceable firearms, Extreme Risk Protection Orders, COPS grants, computer crime, IP theft, sentencing reform, FirstNet, online child sexual exploitation, encryption, Sec. 230 reform, catalytic converter theft, Medicaid Inmate Exclusion Policy, forensic genetic genealogy, rape kit backlog, World Trade Center Health Program, Overt Human Intelligence Collection Program, 1033 Program, H.R.3565 - Spectrum Auction Reauthorization Act of 2023, H.R.2670 - National Defense Authorization Act for Fiscal Year 2024, H.R.4639 - Fourth Amendment Is Not For Sale Act, H.R.4632/S. 2298 - National ACERT Grant Program Authorization Act, H.R. 3150 - OPIOIDS Act, H.R.3563 - STRIP Act, S. 2596/H.R.4958 - Kenneth P. Thompson Begin Again Act, S.2681/H.R. 5005 - Safer Supervision Act of 2023, H.R. 1525 - FAIR Act, H.R.2770 - Prevent Family Fire Act of 2023, H.R. 5460 - Bolstering Security Against Ghost Guns Act, S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023, H.R.4283 - Gun Violence Prevention and Safe Communities Act of 2023, S.2644 - American Law Enforcement SAVER Act, S.1387/H.R. 4384 - Project Safe Neighborhoods Reauthorization Act of 2023, S.1080 - Cooper Davis Act, S.2214 - Fair Legal Access Grants Act, S.2292 - Purchased Data Inventory Act, S.1530 - COPS on the Beat Grant Program Parity Act of 2023, S.2313 - Driving for Opportunity Act of 2023, S.2567 - Stop Computer Crimes Proliferation Act of 2023, S.2597 - Digital Consumer Protection Commission Act of 2023, S. 546 - Recruit and Retain Act, S.2788 - Prohibiting Punishment of Acquitted Conduct Act of 2023, S. 1207 - EARN IT Act of 2023, S. 2601 - Catalytic Converter Task Force Act, H.R. 612/S. 154 - PART Act, S.2566 - American IDEA Act, H.R. 1105 - Debbie Smith Act of 2023, H.R. 5721 - Rape Kit Backlog Act of 2023, H.R. 4531 - SUPPORT Act, H.R.5736 - Federal Accountability in Interviews Reform Act, H.R.3074/S.971 - Due Process Continuity of Care Act, H.R. 2400 - Reentry Act, S. 2103 - Intelligence Authorization for FY 2024, S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, S. 2625/H.R.4367 - Department of Homeland Security Appropriations Act, 2024
2023 · fourth_quarter · Science/Technology
Law enforcement policy and operations, law enforcement grants and funding, law enforcement training, federal-local law enforcement partnerships, violent crime, gun violence, policing reform, officer health and wellness, Next Generation 911, spectrum policy, law enforcement communications, data privacy, law enforcement access to third-party data, American Data Privacy and Protection Act, CJS appropriations, DHS appropriations, FEMA preparedness grants, cUAS, officer safety, COPS grants, Project Safe Neighborhoods, officer safety, computer crime, IP theft, FirstNet, encryption, forensic genetic genealogy, rape kit backlog, H.R.3565 - Spectrum Auction Reauthorization Act of 2023, H.R.2670 - National Defense Authorization Act for Fiscal Year 2024, H.R.4639 - Fourth Amendment Is Not For Sale Act, S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023, S.2644 - American Law Enforcement SAVER Act, S.1387/H.R. 4384 - Project Safe Neighborhoods Reauthorization Act of 2023, S.2292 - Purchased Data Inventory Act, S.1530 - COPS on the Beat Grant Program Parity Act of 2023, S.2567 - Stop Computer Crimes Proliferation Act of 2023, S.2597 - Digital Consumer Protection Commission Act of 2023, S. 1207 - EARN IT Act of 2023, S.2566 - American IDEA Act, H.R. 1105 - Debbie Smith Act of 2023, H.R. 5721 - Rape Kit Backlog Act of 2023, S. 2103 - Intelligence Authorization for FY 2024, S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, S. 2625/H.R.4367 - Department of Homeland Security Appropriations Act, 2024
Client expense: $24,000 · Firm income: Not reported
2023 · fourth_quarter · Copyright/Patent/Trademark
H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request
Client expense: Not reported · Firm income: Not reported
2023 · third_quarter · Copyright/Patent/Trademark
S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S. 835/H.R. 1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R. 2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 H.R. 1398/S. 511, Protect Americas Innovation and Economic Security from CCP Act H.R. 5429/S. 2780, Medication Affordability and Patent Integrity Act Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request
2023 · third_quarter · Homeland Security
Law enforcement policy and operations, law enforcement grants and funding, law enforcement training, federal-local law enforcement partnerships, Next Generation 911, spectrum policy, law enforcement communications, data privacy, law enforcement access to third-party data, American Data Privacy and Protection Act, CJS appropriations, DHS appropriations, FEMA preparedness grants, opioids, fentanyl, drug trafficking, asset forfeiture, human trafficking, ghost guns, firearms trafficking, counterterrorism and mass casualty attacks, cross-border smuggling, cUAS, counterfeit drugs, untraceable firearms, computer crime, IP theft, FirstNet, online child sexual exploitation, encryption, World Trade Center Health Program, Overt Human Intelligence Collection Program, 1033 Program, H.R.3565 - Spectrum Auction Reauthorization Act of 2023, H.R.2670 - National Defense Authorization Act for Fiscal Year 2024, H.R.4639 - Fourth Amendment Is Not For Sale Act, HH.R. 3150 - OPIOIDS Act, H.R.3563 - STRIP Act, H.R. 1525 - FAIR Act, H.R. 5460 - Bolstering Security Against Ghost Guns Act, S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023, S.2644 - American Law Enforcement SAVER Act, S.2292 - Purchased Data Inventory Act, S.2567 - Stop Computer Crimes Proliferation Act of 2023, S.2566 - American IDEA Act, H.R. S. 2103 - Intelligence Authorization for FY 2024, S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, S. 2625/H.R.4367 - Department of Homeland Security Appropriations Act, 2024
Client expense: $30,000 · Firm income: Not reported
2023 · third_quarter · Budget/Appropriations
Law enforcement policy and operations, law enforcement grants and funding, law enforcement training, federal-local law enforcement partnerships, violent crime, gun violence, policing reform, officer health and wellness, recruitment and retention, criminal justice reform, Next Generation 911, spectrum policy, law enforcement communications, CJS appropriations, DHS appropriations, FEMA preparedness grants, alternative responses, criminal record sealing and expungement, reentry policy, VICTIM Act, hate crimes, asset forfeiture, gun safety, youth summer employment programs, mental health and substance abuse, Project Safe Neighborhoods, Extreme Risk Protection Orders, COPS grants, computer crime, IP theft, catalytic converter theft, Medicaid Inmate Exclusion Policy, forensic genetic genealogy, rape kit backlog, World Trade Center Health Program, H.R.3565 - Spectrum Auction Reauthorization Act of 2023, H.R.2670 - National Defense Authorization Act for Fiscal Year 2024, H.R.4632/S. 2298 - National ACERT Grant Program Authorization Act, H.R. 3150 - OPIOIDS Act, H.R. 1525 - FAIR Act, H.R.2770 - Prevent Family Fire Act of 2023, H.R.4283 - Gun Violence Prevention and Safe Communities Act of 2023, S.2644 - American Law Enforcement SAVER Act, S.1387/H.R. 4384 - Project Safe Neighborhoods Reauthorization Act of 2023, S.2214 - Fair Legal Access Grants Act, S.2313 - Driving for Opportunity Act of 2023, S.2567 - Stop Computer Crimes Proliferation Act of 2023, S. 546 - Recruit and Retain Act, H.R. 612/S. 154 - PART Act, S.2566 - American IDEA Act, H.R. 1105 - Debbie Smith Act of 2023, H.R. 5721 - Rape Kit Backlog Act of 2023, H.R. 4531 - SUPPORT Act, H.R.3074/S.971 - Due Process Continuity of Care Act, H.R. 2400 - Reentry Act, S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, S. 2625/H.R.4367 - Department of Homeland Security Appropriations Act, 2024
2023 · third_quarter · Law Enforcement/Crime/Criminal Justice
Law enforcement policy and operations, law enforcement grants and funding, law enforcement training, federal-local law enforcement partnerships, violent crime, gun violence, firearms policy, criminal justice system accountability, policing reform, officer health and wellness, recruitment and retention, criminal justice reform, Next Generation 911, spectrum policy, law enforcement communications, bail reform, data privacy, law enforcement access to third-party data, American Data Privacy and Protection Act, CJS appropriations, DHS appropriations, FEMA preparedness grants, alternative responses, opioids, fentanyl, drug trafficking, criminal record sealing and expungement, reentry policy, parole, post-release supervision, VICTIM Act, hate crimes, asset forfeiture, human trafficking, gun safety, ghost guns, firearms trafficking, counterterrorism and mass casualty attacks, cross-border smuggling, cUAS, youth summer employment programs, juvenile crime, mental health and substance abuse, officer safety, Project Safe Neighborhoods, counterfeit drugs, untraceable firearms, Extreme Risk Protection Orders, COPS grants, computer crime, IP theft, sentencing reform, FirstNet, online child sexual exploitation, encryption, Sec. 230 reform, catalytic converter theft, Medicaid Inmate Exclusion Policy, forensic genetic genealogy, rape kit backlog, World Trade Center Health Program, Overt Human Intelligence Collection Program, 1033 Program, H.R.3565 - Spectrum Auction Reauthorization Act of 2023, H.R.2670 - National Defense Authorization Act for Fiscal Year 2024, H.R.4639 - Fourth Amendment Is Not For Sale Act, H.R.4632/S. 2298 - National ACERT Grant Program Authorization Act, H.R. 3150 - OPIOIDS Act, H.R.3563 - STRIP Act, S. 2596/H.R.4958 - Kenneth P. Thompson Begin Again Act, S.2681/H.R. 5005 - Safer Supervision Act of 2023, H.R. 1525 - FAIR Act, H.R.2770 - Prevent Family Fire Act of 2023, H.R. 5460 - Bolstering Security Against Ghost Guns Act, S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023, H.R.4283 - Gun Violence Prevention and Safe Communities Act of 2023, S.2644 - American Law Enforcement SAVER Act, S.1387/H.R. 4384 - Project Safe Neighborhoods Reauthorization Act of 2023, S.1080 - Cooper Davis Act, S.2214 - Fair Legal Access Grants Act, S.2292 - Purchased Data Inventory Act, S.1530 - COPS on the Beat Grant Program Parity Act of 2023, S.2313 - Driving for Opportunity Act of 2023, S.2567 - Stop Computer Crimes Proliferation Act of 2023, S.2597 - Digital Consumer Protection Commission Act of 2023, S. 546 - Recruit and Retain Act, S.2788 - Prohibiting Punishment of Acquitted Conduct Act of 2023, S. 1207 - EARN IT Act of 2023, S. 2601 - Catalytic Converter Task Force Act, H.R. 612/S. 154 - PART Act, S.2566 - American IDEA Act, H.R. 1105 - Debbie Smith Act of 2023, H.R. 5721 - Rape Kit Backlog Act of 2023, H.R. 4531 - SUPPORT Act, H.R.5736 - Federal Accountability in Interviews Reform Act, H.R.3074/S.971 - Due Process Continuity of Care Act, H.R. 2400 - Reentry Act, S. 2103 - Intelligence Authorization for FY 2024, S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, S. 2625/H.R.4367 - Department of Homeland Security Appropriations Act, 2024
2023 · third_quarter · Science/Technology
Law enforcement policy and operations, law enforcement grants and funding, law enforcement training, federal-local law enforcement partnerships, violent crime, gun violence, policing reform, officer health and wellness, Next Generation 911, spectrum policy, law enforcement communications, data privacy, law enforcement access to third-party data, American Data Privacy and Protection Act, CJS appropriations, DHS appropriations, FEMA preparedness grants, cUAS, officer safety, COPS grants, Project Safe Neighborhoods, officer safety, computer crime, IP theft, FirstNet, encryption, forensic genetic genealogy, rape kit backlog, H.R.3565 - Spectrum Auction Reauthorization Act of 2023, H.R.2670 - National Defense Authorization Act for Fiscal Year 2024, H.R.4639 - Fourth Amendment Is Not For Sale Act, S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023, S.2644 - American Law Enforcement SAVER Act, S.1387/H.R. 4384 - Project Safe Neighborhoods Reauthorization Act of 2023, S.2292 - Purchased Data Inventory Act, S.1530 - COPS on the Beat Grant Program Parity Act of 2023, S.2567 - Stop Computer Crimes Proliferation Act of 2023, S.2597 - Digital Consumer Protection Commission Act of 2023, S. 1207 - EARN IT Act of 2023, S.2566 - American IDEA Act, H.R. 1105 - Debbie Smith Act of 2023, H.R. 5721 - Rape Kit Backlog Act of 2023, S. 2103 - Intelligence Authorization for FY 2024, S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, S. 2625/H.R.4367 - Department of Homeland Security Appropriations Act, 2024
Client expense: $30,000 · Firm income: Not reported
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Client expense: $1,760,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Client expense: $1,760,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Client expense: $24,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
Client expense: $24,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Client expense: $10,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, White House Office